Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H17ClFNO |
| Molecular Weight | 353.817 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=CC=C1C(=O)C2=C(Cl)C=C(NC3=CC=C(F)C=C3C)C=C2
InChI
InChIKey=QIBLVZMAUUVSMB-UHFFFAOYSA-N
InChI=1S/C21H17ClFNO/c1-13-5-3-4-6-17(13)21(25)18-9-8-16(12-19(18)22)24-20-10-7-15(23)11-14(20)2/h3-12,24H,1-2H3
| Molecular Formula | C21H17ClFNO |
| Molecular Weight | 353.817 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 16:46:53 GMT 2025
by
admin
on
Tue Apr 01 16:46:53 GMT 2025
|
| Record UNII |
WX9Y9W9AAY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
344457-87-0
Created by
admin on Tue Apr 01 16:46:53 GMT 2025 , Edited by admin on Tue Apr 01 16:46:53 GMT 2025
|
PRIMARY | |||
|
9798659
Created by
admin on Tue Apr 01 16:46:53 GMT 2025 , Edited by admin on Tue Apr 01 16:46:53 GMT 2025
|
PRIMARY | |||
|
WX9Y9W9AAY
Created by
admin on Tue Apr 01 16:46:53 GMT 2025 , Edited by admin on Tue Apr 01 16:46:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Originator: LEO Pharma; Class: Anti-inflammatory; Mechanism of Action: Immunosuppressant; Highest Development Phase: Discontinued for Dermatitis; Most Recent Event: 13 May 2003 Discontinued - Phase-II for Dermatitis in Europe (unspecified route)
EO-1606 is a topical anti-inflammatory agent that was under development with the Danish company LEO Pharma A/S (formerly Leo Pharmaceutical Products).
|
